Perceel 1 Hepatitis A volwassenen
About This Opportunity
Award notice from Veiligheidsregio Fryslân (Netherlands) — Perceel 1 Hepatitis A. healthcare. Awarded to GlaxoSmithKline B.V.; Sanofi B.V (EUR 8, Sep 2025).
This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Netherlands, Europe, this opportunity is open to firms and consortiums.
Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
This tender, originating from the Netherlands and published via the TED (Tenders Electronic Daily) platform, concerns the procurement of Hepatitis A vaccine for adults. The contracting authority, managed by the Publications Office of the European Union, is seeking a reliable supply of this crucial pharmaceutical product.
The core requirement is for a vaccine effective in preventing Hepatitis A infection in adult populations. While specific dosage, packaging, and delivery schedules will be detailed within the full tender documentation, typical requirements for such procurements often include adherence to stringent European Medicines Agency (EMA) guidelines for quality, safety, and efficacy. Bidders are expected to demonstrate robust manufacturing capabilities, a strong track record in pharmaceutical supply chain management, and the ability to meet potentially significant volume demands.
Further details regarding the technical specifications, including the exact type of vaccine formulation, required shelf-life, storage and handling conditions, and any specific immunogenicity requirements, are outlined in Chapter 2.5 of the official Request for Quotation (RFQ). Interested parties should consult this section thoroughly to ensure their offering meets all mandatory criteria.
This procurement represents an opportunity for pharmaceutical manufacturers and distributors to supply a vital public health resource within the European Union.
Data provenance
This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on December 15, 2025. Last refreshed 15 days ago. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Veiligheidsregio Fryslân
Veiligheidsregio Fryslân has issued 19 procurement notices on BidsFactory, including 3 currently open and 10 awarded contracts. Activity concentrates in General Supplies & Services, Architecture & Engineering Services, and Construction & Civil Works. All notices are published for Netherlands. Notices are distributed via TED - Tenders Electronic Daily (EU) and Netherlands TenderNed. Most recent publication: July 5, 2026.
Frequently asked questions about this tender
Who is the contracting authority?
This notice was issued by Veiligheidsregio Fryslân in Netherlands. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
How much was the contract awarded for?
GlaxoSmithKline B.V.; Sanofi B.V.; Valneva SE was awarded the contract for €8. The figure reflects the value disclosed by the contracting authority in the award notice.
Where will the contract be performed?
The contract is for delivery in Netherlands. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to GlaxoSmithKline B.V.; Sanofi B.V.; Valneva SE. The award notice is archived on BidsFactory for transparency and market intelligence.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.
Sectors & Categories
Key Details
Contracting Authority
Companies That Won Similar
Companies with awards in Health & Medical in Netherlands